These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7734374)

  • 1. Co-segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein C.
    Beufé S; Borg JY; Vasse M; Charbonnier F; Moreau V; Monconduit M; Frebourg T
    Br J Haematol; 1995 Mar; 89(3):659-62. PubMed ID: 7734374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein c resistance (APC) and inherited factor V (FV) mis-sense mutation in patients with venous and arterial thrombosis in a haematology clinic.
    Ma DD; Aboud MR; Williams BG; Isbister JP
    Aust N Z J Med; 1995 Apr; 25(2):151-4. PubMed ID: 7605298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thrombosis in older people: prevalence of the factor V gene mutation Q506.
    André E; Siguret V; Alhenc-Gelas M; Saint-Jean O; Gaussem P
    J Am Geriatr Soc; 1998 Dec; 46(12):1545-9. PubMed ID: 9848816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism.
    Martinelli I; Cattaneo M; Panzeri D; Mannucci PM
    Thromb Haemost; 1997 Mar; 77(3):440-3. PubMed ID: 9065990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B; Svensson PJ; He X; Dahlbäck B
    J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM; Koeleman BP; Koster T; Rosendaal FR; Dirven RJ; de Ronde H; van der Velden PA; Reitsma PH
    Nature; 1994 May; 369(6475):64-7. PubMed ID: 8164741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis.
    Dahlbäck B; Hillarp A; Rosen S; Zöller B
    Ann Hematol; 1996 Apr; 72(4):166-76. PubMed ID: 8624369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thrombosis: factor V G1691A genotyping related to APC resistance as measured by 2 methods.
    Alderborn A; Siegbahn A; Wadelius C
    Eur J Haematol; 1997 Apr; 58(4):229-32. PubMed ID: 9186532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilia as a multigenic disease.
    Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
    Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
    Aparicio C; Dahlbäck B
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population study of the G1691A mutation (R506Q, FV Leiden) in the human factor V gene that is associated with resistance to activated protein C.
    Braun A; Müller B; Rosche AA
    Hum Genet; 1996 Feb; 97(2):263-4. PubMed ID: 8566967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thrombosis in a replanted finger with underlying factor V Leiden mutation.
    Kenner L; Schwarzl F; Moshammer H; Haas F; Hoefler G; Pierer G
    Br J Plast Surg; 1998 Jan; 51(1):57-8. PubMed ID: 9577320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.
    Dahlbäck B
    Haemostasis; 1994; 24(2):139-51. PubMed ID: 7959362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation.
    Bontempo FA; Hassett AC; Faruki H; Steed DL; Webster MW; Makaroun MS
    J Vasc Surg; 1997 Feb; 25(2):271-5; discussion 276. PubMed ID: 9052561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.
    Zöller B; Hillarp A; Berntorp E; Dahlbäck B
    Annu Rev Med; 1997; 48():45-58. PubMed ID: 9046944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.